The score rose 1 point, mainly due to valuation and price changes. Price fell 0.6%, from $112.28 to $111.59. Reported EPS was unchanged, so the lower price improved valuation support.

The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Historical cheapness: current PE is 17.8× versus the full-history median of 18.2× shown in the valuation table, producing 51.7/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 48.1/100. The model applies a 4.4% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 18.1× (18-month half-life). The favorable scenario uses 18.1× PE and $7 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Business trends are mixed. Over the past year: revenue -0.9%, earnings -39.5%, operating margin -0 percentage points. Free cash flow is 22.5% of revenue. The business score is 52.5/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $7.02 of EPS and a 18.1× PE, suggesting a share price of about $127.07 — 15% above today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $5.21 of EPS and a 15.3× PE, suggesting a share price of about $79.62 — 28% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.